FDA PMA FDA Class 3 Approved 🇺🇸 United States

Implant, Anti-Gastroesophageal Reflux

PMA: P100049 · Supplement: S027 · Decision Jun 29, 2020
Classifications
1
FEI Numbers
2
Registration Numbers
2

Basic Information

Device Name
Implant, Anti-Gastroesophageal Reflux
Trade Name
LINX Reflux Management System
PMA Number
P100049
Supplement Number
S027
Device Class
FDA Class 3
Product Code
LEI
Generic Name
IMPLANT, ANTI-GASTROESOPHAGEAL REFLUX
Medical Specialty
Unknown
Advisory Committee
Gastroenterology, Urology
Decision
Approved
Decision Code
APPR
Decision Date
June 29, 2020
Date Received
September 17, 2019
Supplement Type
135 Review Track For 30-Day Notice
Supplement Reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review
N

Advisory Committee Statement

adding a second Hardwell Controlled Environmental Area (CEA).

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
LEI Implant, Anti-Gastroesophageal Reflux